The Central Nervous System as a Sanctuary Site in ALK-Positive Non-Small-Cell Lung Cancer

被引:110
作者
Gainor, Justin F. [1 ]
Ou, Sai-Hong Ignatius [3 ]
Logan, Jennifer [1 ]
Borges, Lawrence F. [2 ]
Shaw, Alice T. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Canc, Dept Neurosurg, Boston, MA 02114 USA
[3] Univ Calif Irvine, Dept Med, Orange, CA 92668 USA
基金
美国国家卫生研究院;
关键词
Anaplastic lymphoma kinase; ALK; Intramedullary spinal cord metastasis; Leptomeningeal carcinomatosis; BRAIN METASTASES; CRIZOTINIB; ADENOCARCINOMA;
D O I
10.1097/JTO.0000000000000029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic lymphoma kinase (ALK) gene rearrangements define a distinct molecular subset of non-small-cell lung cancer that is highly responsive to treatment with the ALK inhibitor crizotinib. Recently, it has been recognized that the brain is a frequent site of relapse among ALK-positive patients treated with crizotinib. In this report, we expand on these observations and present a series of ALK-positive patients with two distinct forms of metastatic, central nervous system involvement: intramedullary spinal cord metastasis and leptomeningeal carcinomatosis.
引用
收藏
页码:1570 / 1573
页数:4
相关论文
共 21 条
[1]   ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis [J].
Ahn, Hee Kyung ;
Han, Boram ;
Lee, Su Jin ;
Lim, Taekyu ;
Sun, Jong-Mu ;
Ahn, Jin Seok ;
Ahn, Myung-Ju ;
Park, Keunchil .
LUNG CANCER, 2012, 76 (02) :253-254
[2]   Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC) [J].
Camidge, D. Ross ;
Ou, Sai-Hong Ignatius ;
Shapiro, Geoffrey ;
Otterson, Gregory Alan ;
Villaruz, Liza Cosca ;
Villalona-Calero, Miguel Angel ;
Iafrate, A. John ;
Varella-Garcia, Marileila ;
Dacic, Sanja ;
Cardarella, Stephanie ;
Zhao, Weiqiang ;
Tye, Lesley ;
Stephenson, Patricia ;
Wilner, Keith D. ;
James, Leonard Philip ;
Socinski, Mark A. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[3]   Taking Aim at ALK Across the Blood-Brain Barrier [J].
Camidge, D. Ross .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) :389-390
[4]   Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study [J].
Camidge, D. Ross ;
Bang, Yung-Jue ;
Kwak, Eunice L. ;
Iafrate, A. John ;
Varella-Garcia, Marileila ;
Fox, Stephen B. ;
Riely, Gregory J. ;
Solomon, Benjamin ;
Ou, Sai-Hong I. ;
Kim, Dong-Wan ;
Salgia, Ravi ;
Fidias, Panagiotis ;
Engelman, Jeffrey A. ;
Gandhi, Leena ;
Jaenne, Pasi A. ;
Costa, Daniel B. ;
Shapiro, Geoffrey I. ;
LoRusso, Patricia ;
Ruffner, Katherine ;
Stephenson, Patricia ;
Tang, Yiyun ;
Wilner, Keith ;
Clark, Jeffrey W. ;
Shaw, Alice T. .
LANCET ONCOLOGY, 2012, 13 (10) :1011-1019
[5]   Carcinoma meningitis secondary to non-small cell lung cancer - Combined modality therapy [J].
Chamberlain, MC ;
Kormanik, P .
ARCHIVES OF NEUROLOGY, 1998, 55 (04) :506-512
[6]   CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib [J].
Costa, Daniel B. ;
Kobayashi, Susumu ;
Pandya, Shuchi S. ;
Yeo, Wee-Lee ;
Shen, Zhongzhou ;
Tan, Weiwei ;
Wilner, Keith D. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :E443-E445
[7]  
GREM JL, 1985, CANCER-AM CANCER SOC, V56, P2305, DOI 10.1002/1097-0142(19851101)56:9<2305::AID-CNCR2820560928>3.0.CO
[8]  
2-X
[9]   Leptomeningeal carcinomatosis [J].
Grossman, SA ;
Krabak, MJ .
CANCER TREATMENT REVIEWS, 1999, 25 (02) :103-119
[10]   Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].
Kwak, Eunice L. ;
Bang, Yung-Jue ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Solomon, Benjamin ;
Maki, Robert G. ;
Ou, Sai-Hong I. ;
Dezube, Bruce J. ;
Jaenne, Pasi A. ;
Costa, Daniel B. ;
Varella-Garcia, Marileila ;
Kim, Woo-Ho ;
Lynch, Thomas J. ;
Fidias, Panos ;
Stubbs, Hannah ;
Engelman, Jeffrey A. ;
Sequist, Lecia V. ;
Tan, WeiWei ;
Gandhi, Leena ;
Mino-Kenudson, Mari ;
Wei, Greg C. ;
Shreeve, S. Martin ;
Ratain, Mark J. ;
Settleman, Jeffrey ;
Christensen, James G. ;
Haber, Daniel A. ;
Wilner, Keith ;
Salgia, Ravi ;
Shapiro, Geoffrey I. ;
Clark, Jeffrey W. ;
Iafrate, A. John .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703